CN103865993A - 肿瘤靶向药物有效性检测、突变富集方法、引物对及试剂 - Google Patents
肿瘤靶向药物有效性检测、突变富集方法、引物对及试剂 Download PDFInfo
- Publication number
- CN103865993A CN103865993A CN201210551712.3A CN201210551712A CN103865993A CN 103865993 A CN103865993 A CN 103865993A CN 201210551712 A CN201210551712 A CN 201210551712A CN 103865993 A CN103865993 A CN 103865993A
- Authority
- CN
- China
- Prior art keywords
- primer pair
- primer
- seq
- sequence shown
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
引物对 | 突变位点 | 上游引物 | 下游引物 |
A | a | GCTTGTGGAGCCTCTTACA | GCCAGGGACCTTACCTTAT |
B | b | CTGTCATAGGGACTCTGG | CACAGCAAAGCAGAAACT |
C | c | ATGCGAAGCCACACTGAC | CTTTGTGTTCCCGGACATAG |
D | d | GCAGGGTCTTCTCTGTTTCA | TACTTTGCCTCCTTCTGCAT |
E | e | GTCCTGCACCAGTAATATGC | AACCTTATGTGTGACATGTTCTAAT |
F | f | TGTGTTTCTCCCTTCTCAGG | GTACTGGTCCCTCATTGCAC |
G | g | AAACAGGCTCAGGACTTA | GATTTTGCAGAAAACAGA |
H | h | GCTCTGATAGGAAAATGA | ACTGTTCAAACTGATGGG |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210551712.3A CN103865993B (zh) | 2012-12-18 | 2012-12-18 | 肿瘤靶向药物有效性检测、突变富集方法、引物对及试剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210551712.3A CN103865993B (zh) | 2012-12-18 | 2012-12-18 | 肿瘤靶向药物有效性检测、突变富集方法、引物对及试剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103865993A true CN103865993A (zh) | 2014-06-18 |
CN103865993B CN103865993B (zh) | 2018-09-25 |
Family
ID=50904999
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210551712.3A Active CN103865993B (zh) | 2012-12-18 | 2012-12-18 | 肿瘤靶向药物有效性检测、突变富集方法、引物对及试剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103865993B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105063208A (zh) * | 2015-08-10 | 2015-11-18 | 北京吉因加科技有限公司 | 一种血浆中游离的目标dna低频突变富集测序方法 |
CN105256021A (zh) * | 2015-10-16 | 2016-01-20 | 福建医科大学 | 基于Sanger测序灵敏检测人类EGFR基因突变的方法及其试剂盒 |
CN105420351A (zh) * | 2015-10-16 | 2016-03-23 | 深圳华大基因研究院 | 确定个体基因突变的方法和系统 |
CN105567854A (zh) * | 2016-03-01 | 2016-05-11 | 济南银丰医学检验有限公司 | 一种检测人egfr、kras、braf基因突变的引物组合及其试剂盒 |
CN105821120A (zh) * | 2016-02-03 | 2016-08-03 | 广州医科大学附属肿瘤医院 | 一种基于巢式复合cold-pcr的t790m突变检测方法 |
CN105861650A (zh) * | 2016-04-06 | 2016-08-17 | 广东凯普生物科技股份有限公司 | Egfr基因突变检测试剂盒 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102115792A (zh) * | 2010-12-20 | 2011-07-06 | 苏州科贝生物技术有限公司 | 一种检测人结直肠癌kras基因突变的方法和试剂盒 |
-
2012
- 2012-12-18 CN CN201210551712.3A patent/CN103865993B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102115792A (zh) * | 2010-12-20 | 2011-07-06 | 苏州科贝生物技术有限公司 | 一种检测人结直肠癌kras基因突变的方法和试剂盒 |
Non-Patent Citations (4)
Title |
---|
A. PENNYCUICK,ET AL: "Routine EGFR and KRAS Mutation analysis using COLD-PCR in non-small cell lung cancer", 《INT J CLIN PRACT》 * |
G-C. ZHANG,ET AL: "Epidermal Growth Factor Receptor Double Activating Mutations Involving Both Exons 19 and 21 Exist in Chinese Non-small Cell Lung Cancer Patients", 《CLINICAL ONCOLOGY》 * |
IRENE MANCINI,ET AL: "The Use of COLD-PCR and High-Resolution Melting Analysis Improves the Limit of Detection of KRAS and BRAF Mutations in Colorectal Cancer", 《JOURNAL OF MOLECULAR DIAGNOSTICS》 * |
JIN LI,ET AL: "Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing", 《NATURE MEDICINE》 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105063208A (zh) * | 2015-08-10 | 2015-11-18 | 北京吉因加科技有限公司 | 一种血浆中游离的目标dna低频突变富集测序方法 |
CN105063208B (zh) * | 2015-08-10 | 2018-03-06 | 北京吉因加科技有限公司 | 一种血浆中游离的目标dna低频突变富集测序方法 |
CN105256021A (zh) * | 2015-10-16 | 2016-01-20 | 福建医科大学 | 基于Sanger测序灵敏检测人类EGFR基因突变的方法及其试剂盒 |
CN105420351A (zh) * | 2015-10-16 | 2016-03-23 | 深圳华大基因研究院 | 确定个体基因突变的方法和系统 |
CN105256021B (zh) * | 2015-10-16 | 2018-07-24 | 福建医科大学 | 基于Sanger测序灵敏检测人类EGFR基因突变的方法及其试剂盒 |
CN105821120A (zh) * | 2016-02-03 | 2016-08-03 | 广州医科大学附属肿瘤医院 | 一种基于巢式复合cold-pcr的t790m突变检测方法 |
CN105821120B (zh) * | 2016-02-03 | 2019-04-30 | 广州医科大学附属肿瘤医院 | 一种基于巢式复合cold-pcr的t790m突变检测方法 |
CN105567854A (zh) * | 2016-03-01 | 2016-05-11 | 济南银丰医学检验有限公司 | 一种检测人egfr、kras、braf基因突变的引物组合及其试剂盒 |
CN105861650A (zh) * | 2016-04-06 | 2016-08-17 | 广东凯普生物科技股份有限公司 | Egfr基因突变检测试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
CN103865993B (zh) | 2018-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108004301B (zh) | 基因目标区域富集方法及建库试剂盒 | |
CN104818320B (zh) | 一次性检测肺癌多重基因的引物、探针、检测体系和试剂盒 | |
CN103865993A (zh) | 肿瘤靶向药物有效性检测、突变富集方法、引物对及试剂 | |
CN107083438A (zh) | 检测egfr基因20外显子t790m和c797s突变的引物、探针及方法 | |
CN104531854B (zh) | 检测西妥昔单抗治疗转移性结直肠癌耐药的试剂盒 | |
Reclusa et al. | Exosomes genetic cargo in lung cancer: a truly Pandora’s box | |
CN104745679A (zh) | 一种无创检测egfr基因突变的方法及试剂盒 | |
CN108949990A (zh) | 一种检测egfr基因突变的试剂盒及方法 | |
CN107299139A (zh) | 一种用于检测微卫星不稳定性的组合物及其应用 | |
CN105969857A (zh) | 非小细胞肺癌靶向治疗基因检测方法 | |
CN103382503B (zh) | Egfr基因19号外显子19种缺失突变检测试剂盒及检测方法 | |
CN107760784A (zh) | 环状RNA circ‑FOXP1的用途 | |
CN105986031A (zh) | 肿瘤易感62基因及其应用 | |
CN105886648A (zh) | 用于检测egfr基因t790m突变的试剂盒 | |
CN110343748A (zh) | 基于高通量靶向测序分析肿瘤突变负荷的方法 | |
CN102220413B (zh) | 检测表皮生长因子受体基因外显子19缺失突变和外显子21点突变的方法 | |
CN110257518B (zh) | 一种用于预测转移性结直肠癌转化治疗疗效的基因集 | |
CN104498606B (zh) | microRNAs在制备早期筛查或诊断Brachyury阳性肿瘤试剂或试剂盒中的应用 | |
CN105861726A (zh) | Braf基因突变检测试剂盒 | |
CN105506138B (zh) | Ret融合基因arms荧光定量pcr分型检测试剂盒 | |
CN108660211A (zh) | 一种与肝细胞癌相关的生物标志物linc01549及其应用 | |
CN105821120B (zh) | 一种基于巢式复合cold-pcr的t790m突变检测方法 | |
CN107586851A (zh) | 一种kras、nras、braf基因突变检测试剂盒 | |
CN108660193A (zh) | 人类lmna-ntrk1基因融合突变检测引物、探针及检测试剂盒 | |
CN114350812A (zh) | 与奥西替尼耐药性相关的NSCLC-free RNA-3及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: BGI-SHENZHEN CO., LTD. Effective date: 20150804 Owner name: SHENZHEN BGI CORPORATION Free format text: FORMER OWNER: BGI-SHENZHEN Effective date: 20150804 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20150804 Address after: Yantian District of Shenzhen City, Guangdong province 518000 Hongan street No. 21 China Comprehensive Park 7 Building 7 layer -14 layer Applicant after: BGI SHENZHEN CO LTD Address before: 518053 comprehensive building, Beishan Industrial Zone, Yantian District, Guangdong, Shenzhen Applicant before: BGI-Shenzhen Applicant before: BGI-Shenzhen Co., Ltd. |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20181214 Address after: 518083 Huada Complex Park, 21 Hongan Third Street, Yantian District, Shenzhen City, Guangdong Province, 7 buildings, 7 floors-14 floors Co-patentee after: Huada biological technology (Wuhan) Co., Ltd. Patentee after: BGI SHENZHEN CO LTD Address before: 518000 Huada Complex Garden, 21 Hongan Third Street, Yantian District, Shenzhen City, Guangdong Province, 7 buildings, 7 floors-14 floors Patentee before: BGI SHENZHEN CO LTD |